Arnoco, Mary Joy .
HRN: 23-11-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 1.5GM (VIAL)
05/24/2023
05/25/2023
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary CS With IUD Insertion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes